| Filed On | Filing |
|---|---|
| 12 Aug 2024 |
8-K/A: Results of Operations and Financial Condition
Completed enrollment of initial Cohort 2 patients in its VMT-α-NET and VMT01 clinical trials |
| 17 Jan 2024 |
8-K/A: Financial Statements and Exhibits
Certain information has been excluded from this exhibit (indicated by “[***]”) because such information is both (i) not material and (ii) the type that the company treats as private or confidential. |
| 21 Apr 2023 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Viewpoint Molecular Targeting, Inc. (the “Company”) as of December 31, 2022 and 2021, the related statements of operations, stockholders’ equity (deficit), and cash flows for the years t... |
| 23 Jan 2017 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Amendment No. 1 to Form 8-K amends the Current Report on Form 8-K filed by IsoRay, Inc. (the “Company”) on January 17, 2017 (the “Original Report”), to disclose that Matthew Branson was appointed as both principal financial officer ... |
| 16 May 2014 |
8-K/A: Submission of Matters to a Vote of Security Holders
On March 5, 2014, IsoRay, Inc. held its Fiscal 2014 Annual Meeting of Stockholders. Proposal Four (the non-binding, advisory proposal to express preference as to the frequency of stockholder advisory votes on the Company’s executive comp... |
| 24 Mar 2014 |
8-K/A: Financial Statements and Exhibits
IsoRay, Inc., Prospectus Supplement to Registration Statement on Form S-3 |
| 21 Mar 2013 |
8-K/A: Entry into a Material Definitive Agreement
Open Joint Stock Company <<Institute of The Nuclear Materials>> (JSC<<INM>>) |
| 17 Jul 2012 |
8-K/A: Financial Statements and Exhibits
IsoRay, Inc., Prospectus Supplement to Registration Statement on Form S-3 |
| 19 Aug 2011 |
8-K/A: Entry into a Material Definitive Agreement
THIS AGREEMENT (hereinafter referred to as this Agreement) is made as of this 1st day of the month of June, 2011 (Effective Date) by and between |
| 24 Nov 2010 |
8-K/A: Financial Statements and Exhibits
IsoRay, Inc., Prospectus Supplement to Registration Statement on Form S-3 (Registration No. 333-162694) |
| 02 May 2006 |
8-K/A: Entry into a Material Definitive Agreement
IBt, a Société Anonyme incorporated in Belgium, having its registered office at 7180 Seneffe, Rue Jules Bordet 1, Zone Industrielle C, Belgium, |
| 15 Aug 2005 |
8-K/A: Departure/Election of Directors or Officers; Compensation
We have audited the accompanying balance sheet of IsoRay Medical, Inc. (“the Company”) (a Development Stage Enterprise) as of March 31, 2005, and the related statements of operations, changes in shareholders’ equity (deficit) and cash fl... |
| 24 Oct 1996 |
8-K/A: Changes in Registrant's Certifying Accountant
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Loading...